4.4 • 1.6K Ratings
🗓️ 17 August 2023
⏱️ 60 minutes
🧾️ Download transcript
There's a new class of weight-loss drugs in town. GLP-1 medications including Ozempic, Wegovy and Mounjaro were created to treat diabetes but have since been found to suppress appetites and induce substantial weight loss. It's a big deal for the companies which make them, with shares of Novo Nordisk and Eli Lilly all soaring in recent weeks. But the drugs could end up having a much broader economic impact too. On this episode, we speak with James van Geelen of Citrinitas Capital, about the second-order effects of effective weight-loss drugs. He talks us through how he's evaluating the potential of the new meds and how he approaches possible 'mega-trends' like GLP-1 or AI.
See omnystudio.com/listener for privacy information.
Click on a timestamp to play from that location
0:00.0 | Oddlots is brought to you by interactive brokers. Access to vast selection of global fixed income securities at IBKR's bond marketplace. Search their deep availability of over 1 million bonds globally. |
0:11.3 | IBKR has no markups or built in spreads and low fully transparent commissions on bonds. IBKR displays the highest bids and lowest offers received from the electronic venues they access. |
0:21.8 | In addition, clients can interact with each other by placing bids and offers online to execute their trades. Learn more at IBKR.com slash bonds. |
0:30.0 | I'm Akshatrati and this summer on my podcast zero, I'm doing a series about climate storytelling, how we talk about climate change and what it means for how we confront it. |
0:40.8 | This week, I'm interviewing journalist Amy Vesterveld about reporting on the history of climate denialism. |
0:46.8 | I'm a big believer in the idea that you can't effectively solve a problem if you don't really know where it came from. |
0:54.6 | Listen to zero on the iHeart Radio app or wherever you get your podcasts. |
0:59.3 | Hello and welcome to another episode of the Odd Lots podcast. I'm Tracy Alloway and I'm Joe Wyzenthal. |
1:16.0 | Joe. Would you ever go on a Zembek? Oh yeah definitely. Yeah. Really? Well you know this seems fun. |
1:24.0 | It reduces your appetite, probably lose weight. It seems like it also has a bunch of other, I keep seeing these other things like, it's good for like you know impulse control and all kinds of positive things. Yeah, why not? |
1:37.3 | Yeah, it's supposed to be good for impulses and addiction and also I think there's some new stat out saying that it reduces the risk of heart attack and stroke by 20%. Well anyway. |
1:47.8 | Would you? I think yes, however, I would definitely wait for the price to come down a little bit and maybe for more of the side effects to become apparent, but I'm very cautious with these sorts of medical breakthroughs. |
2:04.8 | Yeah, I feel like my like I don't know that much about all these drugs like a Zembek and we gov and the other GLP ones, but they seem pretty great and I just like yeah up upward and onward. |
2:16.4 | The march of progress science. I love it. No, but I actually do think like it is something I've been thinking about is like, people are so skeptical of even the possibility of the existence of a wonder drug. |
2:28.5 | Then people are like, oh, it's going to do this. It's going to do this. It's going to be bad. It's going to reverse. It's going to and maybe that's possible. |
2:35.6 | But what if it really is a wonder job? Well, exactly. And I think it opens up a ton of interesting questions specifically about what it means for wider society and the wider economy. |
2:46.7 | When we know that obesity and diseases like diabetes have been this huge weight on both the socio economy and the healthcare industry. |
2:57.6 | Obesity itself is like just this gigantic economic force. It's a business force. There are businesses that thrive on how much people like to eat unhealthy food. |
3:08.0 | There are huge costs to insurers. There are other second order effects of related to injuries and heart, heart complications and so forth. |
3:16.1 | It's such a modern, important phenomenon that were there to be and maybe it kind of looks like there is, but were there to be this sort of like |
3:24.8 | straightforward way to reduce obesity. It seems like the implications would be huge. |
3:29.3 | Right. And I keep getting visions of like Star Trek in my head where everyone is kind of slim and dressed in tracks. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Bloomberg, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Bloomberg and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.